It is reasonable to think that the down expression of miR-100 that we previously observed in low-grade, non-invasive bladder urothelial cancer is related to the lack of control of mTOR and FGFR3 and to the maintenance of genomic stability due to not interfering with SMARCA5. Here, FGFR3 is linked to bladder transitional cell carcinoma.